Drugs / BioCart™II
last change May 2015 re-read 3 minutes ago

BioCart™II

Cell therapy

Developed for
arthropathy
Investigated by
ProChon Biotech Ltd

Trials 1

20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00729716 May 2008 → May 2012 arthropathy ProChon Biotech Ltd Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as BioCartII ClinicalTrials.gov intervention name — accepted as the source's own label NCT00729716 ↗
Modality Cell therapy “the cells are grown and expanded in culture and then returned to the knee to repair the damaged cartilage” NCT00729716 ↗